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Abstract
Background: Nontypeable Haemophilus influenzae is a common cause of otitis media in children and lower
respiratory tract infection in adults with chronic obstructive pulmonary disease (COPD). Prior studies have shown
that H. influenzae expresses abundant urease during growth in the middle ear of the chinchilla and in pooled
human sputum, suggesting that expression of urease is important for colonization and infection in the hostile
environments of the middle ear and in the airways in adults. Virtually nothing else is known about the urease of H.
influenzae, which was characterized in the present study.
Results: Analysis by reverse transcriptase PCR revealed that the ure gene cluster is expressed as a single transcript.
Knockout mutants of a urease structural gene (ureC) and of the entire ure operon demonstrated no detectable
urease activity indicating that this operon is the only one encoding an active urease. The ure operon is present in
all strains tested, including clinical isolates from otitis media and COPD. Urease activity decreased as nitrogen
availability increased. To test the hypothesis that urease is expressed during human infection, purified recombinant
urease C was used in ELISA with pre acquisition and post infection serum from adults with COPD who experienced
infections caused by H. influenzae. A total of 28% of patients developed new antibodies following infection
indicating that H. influenzae expresses urease during airway infection. Bacterial viability assays performed at varying
pH indicate that urease mediates survival of H. influenzae in an acid environment.
Conclusions: The H. influenzae genome contains a single urease operon that mediates urease expression and that
is present in all clinical isolates tested. Nitrogen availability is a determinant of urease expression. H. influenzae
expresses urease during human respiratory tract infection and urease is a target of the human antibody response.
Expression of urease enhances viability in an acid environment. Taken together, these observations suggest that
urease is important for survival and replication of H. influenzae in the human respiratory tract.
Background
Nontypeable (non encapsulated) Haemophilus influenzae
is an exclusively human pathogen whose primary ecolo-
gical niche is the human respiratory tract. H. influenzae
is a common and important human pathogen, causing
otitis media in children and lower respiratory tract
infection in adults with chronic obstructive pulmonary
disease (COPD) [1-3]. The course of COPD, the fourth
leading cause of death in the world, is characterized by
intermittent worsening called exacerbations.
Approximately half of exacerbations are caused by bac-
terial infection, with H. influenzae being the most fre-
quent bacterial cause [2]. In addition to causing
exacerbations, H. influenzae also chronically colonizes
the lower airways of adults with COPD. The normal
human respiratory tract is sterile below the vocal cords,
as determined by culture. However, in adults with
COPD, the lower airways are colonized by bacteria, with
H. influenzae as the most common pathogen in this set-
ting [4-7].
The human respiratory tract is a hostile environment
for bacteria. Nutrients and energy sources are limited.
In the setting of COPD, airways are characterized by an
oxidant/antioxidant imbalance and by an inflammatory
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human respiratory tract, H. influenzae must express pro-
teins and other molecules to enable persistence in this
unique environment.
In previous work, we characterized the proteome of H.
influenzae that was grown in pooled human sputum
obtained from adults with COPD in an effort to simu-
late the environment of the human airways in COPD
[13]. In comparison to the same strain of H. influenzae
grown in chemically defined media, 31 proteins were
present in greater abundance in sputum grown-condi-
tions at a ratio of > 1.5 compared to media-grown con-
ditions. These included antioxidant proteins, stress
response proteins, proteins that function in the uptake
of divalent cations and proteins that function in the
uptake of various molecules. Interestingly, the second
most abundant protein with regard to the ratio of spu-
tum-grown to media-grown analysis was urease C, the
alpha subunit of urease, which was present in an abun-
dance of 7-fold greater in sputum-grown conditions
compared to media-grown conditions. This is an inter-
esting finding in light of the observation by Mason et al
[14] who monitored gene expression by H. influenzae in
the middle ear of a chinchilla, the most widely used ani-
mal model of otitis media. The gene that encodes urease
accessory protein, ureH,w a si n d u c e d3 . 9 - f o l di nb a c t e r -
ial cells in the middle ear compared to baseline. These
two genes, ureC and ureH are part of the urease gene
cluster and were among the most highly up regulated
genes. These observations suggest that expression of
urease is important for survival and growth of H. influ-
enzae in the respiratory tract.
Ureases are nickel dependent enzymes that catalyze
the hydrolysis of urea to form ammonia and carbon
dioxide [15,16]. Urease is best studied as a virulence fac-
tor in Helicobacter pylori which colonizes the stomach
and Proteus mirabilis which causes urinary tract infec-
tions [17-23]. Urease is also important for survival and
pathogenesis of several bacterial species [24-27]. Urease
functions to raise the pH of the environment, allowing
survival in acidic media; urease also enables bacteria to
use urea as a sole nitrogen source [28]. While these are
the best known functions of urease, this protein also
interacts with the human host and acts as virulence fac-
tor by several other mechanisms, including activation of
macrophages [29], induction of inflammatory mediators
[30-32], dysregulation of gastric epithelial tight junctions
[33], apoptosis [34], activation of platelets, enhanced
survival in macrophages [35,36] and others [37,38].
Virtually nothing is known about the urease of H.
influenzae. In view of the high degree of up regulation
of urease expression by H. influenzae in the respiratory
tract and the importance of urease as a virulence factor
in other bacteria, the goal of this study is to characterize
t h eu r e a s eo fH. influenzae. In particular we have con-
structed knockout mutants of ureC and the urease
operon to assess urease activity by H. influenzae, charac-
terized the urease transcript, determined the optimal pH
for urease activity and demonstrated that the urease
operon is present in clinical isolates from otitis media
and COPD. Analysis of pre and post infection serum
samples from adults with exacerbations of COPD caused
by H. influenzae demonstrated directly that urease is
expressed during human infection. Finally, we demon-
strate that urease activity enhances survival of H. influ-
enzae at a reduced pH.
Results
Identification of urease gene cluster
The a subunit of urease, which was present in increased
abundance in H. influenzae g r o w ni np o o l e dh u m a n
sputum based on proteomic analysis, is a protein of 572
amino acids with a predicted molecular mass of 62 kilo-
daltons that is encoded by ureC [13]. The ureC gene is
t h et h i r dg e n ei nt h eu r e a s eg e n ec l u s t e r ,( F i g u r e1 A ) ;
ureA and ureB encode the g and b subunits respectively
and ureE, ureF, ureG and ureH encode urease accessory
proteins. These genes correspond to loci HI0535
through HI0541 in H. influenzae strain KW20 Rd (Gen-
Bank L42023.1) and to loci NTHI 0661 through NTHI
0667 in H. influenzae strain 86-028NP (GenBank
CP000057).
Characterization of mutants
A ureC mutant was constructed in our prototype COPD
exacerbation strain 11P6H by replacing the ureC gene
with a non polar kanamycin resistance cassette by homo-
logous recombination using overlap extension PCR (Fig-
ure 1B). The mutant construct was confirmed by PCR
using oligonucleotide primers in and around the gene in
the wild type strain and the kanamycin cassette in the
mutant, and by sequencing through the region of homo-
logous recombination. An immunoblot assay of whole
cell lysates probed with rabbit antiserum raised to recom-
binant urease C reveals the presence of an ~62 kDa pro-
tein band in the wild type strain, corresponding to urease
C, and no bands in the ureC mutant (Figure 2).
Complementation of the ureC mutation was accom-
plished by cloning a fragment corresponding to the pro-
moter region of the urease operon upstream of ureA
through ureC into plasmid pSPEC and transforming the
plasmid into the ureC mutant [39]. The complemented
mutant expresses urease C detected by specific anti-
serum (Figure 2, lane d).
A knockout of the entire urease gene cluster was con-
structed using a similar overlap extension PCR strategy
(Figure 1C). The mutant construct was confirmed by
PCR and sequencing through the region of homologous
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terial cell lysate of the urease operon mutant probed
with antiserum to urease C reveals an absence of a
urease C band (Figure 2, lane c) that is present in wild
type.
To further characterize the urease operon mutant,
genomic DNA from wild type and urease operon
mutant strains was purified, restricted with EcoR1 and
subjected to Southern blot assay. Probes that corre-
s p o n d e dt ot h ea m i n ot e r m i n a lr e g i o n( ureA), the
central region (ureC) and the carboxy terminal region
(ureH) of the gene cluster and the kanamycin cassette
revealed an absence of each of these 3 genes in the
mutant and the presence of a kanamycin cassette as
expected (Figure 3).
Characterization of purified recombinant urease C
Recombinant urease C was purified by elution from a
metal affinity column and refolded by sequential dialysis
in buffers that contained decreasing concentrations of
arginine. Analysis of the purified protein by SDS PAGE
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Figure 1 1A. Diagram of urease gene cluster. Numbers above genes indicate length of genes in nucleotides and numbers below indicate
nucleotides between gene coding sequences. 1B. Diagram of ureC knockout mutant. 1C. Diagram of urease operon knockout mutant.
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Figure 2 Characterization of mutants and recombinant urease
C protein. Left panel. Immunoblot assay probed with rabbit
antiserum (1:50,000) raised to recombinant purified urease C and
adsorbed with urease mutant 11P6HureC
-. Blots were probed with
goat anti-rabbit IgG (1:1000) and color was developed with
horseradish peroxide developer. Lanes contain whole cell lysates as
follows: a) Wild type 11P6H; b) Urease C mutant 11P6HureC
-;c )
Urease operon mutant 11P6Hure
-; d) Complemented urease C
mutant 11P6HureC
-(pureC). Right panel. Coomassie blue stained
polyacrylamide gel. Lane e) Purified recombinant urease C. Arrow
denotes full size protein. The lower band is a fragment of the full
size protein. Molecular mass standards are noted on the left of each
panel in kilodaltons.
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Figure 3 Southern blot assay. Purified genomic DNA of H.
influenzae was restricted with EcoRI and hybridized with 200 bp
probes corresponding to ureA, ureC, ureH and kanamycin cassette
(kan) as noted at the bottom of each panel. Lanes a) wild type
strain 11P6H; lanes b) urease operon mutant 11P6Hure
-. Molecular
size markers are noted on the left in kilobases.
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2, lane e). Preparations of the purified protein also
revealed a second band of varying intensity of a lower
molecular mass. Immunoblot assay with antibody that
recognizes the 6 histidine tag detected both bands, indi-
cating that the smaller band resulted from proteolytic
degradation of the full length protein (data not shown).
Protease inhibitors were used during purification and
storage; however the purified protein was prone to pro-
teolytic degradation. The purified recombinant protein
was used to raise antiserum in rabbits and to measure
antibody by ELISA in human serum. Thus, this level of
proteolytic degradation would not be expected to
adversely affect these experiments.
Characterization of urease activity
Crude cell extracts of H. influenzae 11P6H were used to
determine urease activity in wild type 11P6H and
mutant strains. The ureC knockout mutant and the
urease operon mutant both demonstrated no detectable
urease activity compared to wild type and ureC comple-
mented mutant when grown in laboratory media (Figure
4). We conclude that the ureA-H gene cluster accounts
for all detectable urease activity of H. influenzae under
the conditions of this assay. In addition, knocking out
ureC alone, which encodes the major structural subunit
of urease, completely abrogates urease activity.
The optimal pH of H. influenzae urease was determined
by preparing whole cell extracts in phosphate buffers ran-
ging in pH from 4 to 8. The optimal pH for urease was 7,
with marked reduction in activity at lower pH (Figure 5).
To begin to assess factors that control urease expres-
sion in H. influenzae, the effect of nitrogen availability
on urease production was measured by adding increas-
ing concentrations of ammonium chloride to bacteria
growing in broth culture. Urease production decreased
as the concentration of added ammonium chloride
increased (Figure 6).
Analysis of urease transcript
Reverse transcriptase PCR was performed to determine
whether genes ureA through ureH of the urease gene
cluster are transcribed as a single transcript or as
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Figure 4 Urease activity of mutants. Results of urease assays with
wild type, mutants and complemented mutant as noted at bottom.
Urease activity is expressed on the Y-axis as μmoles of urea
hydrolyzed per minute. Results are the mean of 3 independent
assays and error bars denote standard deviation. Urease activity was
undetectable in ureC mutant and ure operon mutant.
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Figure 5 Optimal pH of urease activity. Urease activities of H.
influenzae protein extracts were assayed in buffers of varying pH as
noted on X-axis. Y-axis is urease activity in μmols of urea hydrolyzed
per min. Each point is the average of 3 independent experiments
and error bars indicate standard deviations.
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Figure 6 Expression of urease.U r e a s ea c t i v i t yi nt h ep r e s e n c eo f
varying concentrations of ammonium chloride as noted on the Y-
axis. Results are expressed as a per cent of maximum activity (X-axis)
in the absence of added ammonium chloride. Each bar is the
average of three independent experiments and the error bars
indicate standard deviations.
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formed using RNA isolated from H. influenzae 11P6H
grown in broth using primers designed to correspond to
transcripts that would span adjacent genes in the gene
cluster (Figure 1). Figure 7 shows that the genes of the
urease gene cluster are transcribed as a single transcript.
Control assays confirmed that the purified RNA was
free of contaminating DNA (Figure 7, lanes b).
Presence of urease operon in clinical isolates
To determine whether the urease operon is present in
clinical isolates of Hi n f l u e n z a e , 20 clinical isolates,
including 10 otitis media strains and 10 COPD strains
were studied by PCR. Primers corresponding to genes
located in the 5’ region (ureA), central region (ureC)
and 3’ region (ureH) of the operon were designed.
Amplicons of identical size were obtained from 20 of 20
clinical isolates with all 3 sets of primers (Figure 8).
These results indicate that the urease operon is present
in all strains tested and that no variation was observed
in the lengths of these genes in diverse strains tested.
A BLASTn search with the sequence corresponding to
the urease operon was performed to determine which
strains of H. influenzae whose genomes are available in
GenBank contained the urease operon. Five of 6 strains
whose complete genome has been sequenced contain
the urease operon. A high degree of sequence similarity
in the urease operon is present among the 5 strains. In
strain R2866, which is urease negative, the urease
operon is replaced by a single gene with homology to
the gonococcal mtrF gene [40]. Sequence analysis of the
same region of 9 additional urease negative strains
revealed sequence that is very similar to that of strain
R2866 [40].
Transcription of the ureC during growth in pooled human
sputum
To assess expression of urease in conditions that simu-
late conditions in the human respiratory tract in COPD,
transcription of ureC was measured in H. influenzae
that was grown in the presence of pooled human spu-
tum from adults with COPD in comparison to growth
in the absence of human sputum using quantitative real
time PCR. Results of ureC were normalized with gyrA,a
gene that is constitutively expressed [14]. Transcription
of ureC in media plus sputum was 3.32 ± 0.066 (mean ±
standard deviation) fold greater than transcription of
ureC in media alone (1.0 ± 0.223). We conclude that
transcription of ureC is up regulated when H. influenzae
grows in media with added human sputum compared to
growth in laboratory media alone.
Human antibody responses
To determine whether urease was expressed by H. influ-
enzae during infection of the human respiratory tract,
18 serum pairs from patients who experienced exacerba-
tions due to H. influenzae were assayed for the develop-
ment of antibody to purified recombinant urease
following exacerbation.
The cutoff value for a significant percentage change
between pre-exacerbation and post-exacerbation serum
IgG levels was determined as previously described [41-44].
Eight control pairs of serum samples obtained 2 months
apart (the same time interval for the experimental sam-
ples) from adults with COPD who were clinically stable
and who had negative sputum cultures for H. influenzae
were subjected to ELISA with the purified recombinant
urease. The % change in OD450 values between the paired
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Figure 7 Reverse transcriptase PCR of urease operon.E t h i d i u m
bromide stained agarose gel showing results of reverse
transcriptase PCR with H. influenzae strain 11P6H. Lanes: a) purified
RNA with reverse transcriptase and Taq DNA polymerase; b) purified
RNA with Taq DNA polymerase (negative control); c) purified DNA
with Taq DNA polymerase (positive control). Lane H2O is a water
control. Oligonucleotide primers were designed to span adjacent
genes in the gene cluster as noted at the top of the gel (See Table
1). Molecular size markers are noted in base pairs on the right.
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Figure 8 Urease operon in clinical isolates. Ethidium bromide
stained agarose gels showing amplicons of genes in the urease
gene cluster as noted on the left. Lanes a through j, amplicons from
COPD sputum isolates 6P8H1, 14P14H1, 24P17H1, 27P5H1, 33P18H1,
43P2H1, 55P3H1, 66P33H1, 74P16H1, 91P18H1, respectively. Lanes k
through t, middle ear fluid aspirate isolates 1749, 1826, 6699, 6700,
4R, 17R, 26R, 47R, P86, P113, respectively. Molecular size standards
are noted on the right in kilobases.
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serum samples demonstrated a 3.36% ± 6.01 (mean ± SD)
change when tested with urease. A change in OD of 9.37%
represented the upper limit of the 99% confidence interval
for the control samples. Therefore, any increase in value
from pre to post exacerbation serum pairs of ≤ 9.37% was
regarded as a significant change. A significant increase of
serum IgG antibodies to urease was seen in 7 of 18 serum
pairs (Figure 9). We conclude that H. influenzae expresses
urease during infection of the human respiratory tract and
is a target of human serum antibodies in adults with
COPD.
Susceptibility of H. influenzae to acid conditions
The ability of wild type and urease mutant to survive
exposure to acid was investigated in the presence and
absence of urea. Incubation of H. influenzae at pH 4 in the
absence of urea, resulted in ~35% survival of wild type and
mutant strains. However, in the presence of either 50 mM
or 100 mM urea, survival of the wild type strain increased
whereas no change in survival was observed in the urease
C mutant or the urease operon mutant (Figure 10). Survi-
val of the complemented mutant closely paralleled that of
wild type, supporting the conclusion that urease mediates
survival in acid conditions.
Discussion
As an exclusively human pathogen, H. influenzae
expresses molecules that mediate survival in the hostile
conditions of the human respiratory tract. Previous stu-
dies in animal models and in conditions that simulate
those in the human airways identified urease as a mole-
cule that is expressed in high abundance by H. influen-
zae, providing evidence that urease plays a role in the
pathogenesis of infection. Furthermore, urease activity
may contribute to the pathogenesis of pulmonary infec-
tions due to Actinobacillus pleuropneumoniae in pigs
[45]. These observations lead to the present study which
is the first to characterize H. influenzae urease.
The H. influenzae urease gene cluster resembles that of
other gram negative bacteria, possessing three contiguous
structural genes (ureA, ureB and ureC)t h a te n c o d et h e
urease apoenzyme. Knocking out ureC alone by insertion
of a nonpolar kanamycin cassette in its place resulted in
complete loss of urease activity (Figure 4). Urease is a
multi-subunit enzyme that requires an elaborate pathway
for assembly in its active form. Associated with its three
structural genes are 4 accessory genes which are neces-
sary for synthesis of active enzyme. Based on available
data from other organisms, ureEFG form a complex that
keeps the apoenzyme in a conformation that will accept
nickel. H. influenzae ureH, a structural homolog of ureD,
is located downstream of the ureEFG, similar to the orga-
nization of the H. pylori urease gene cluster. H. influen-
zae does not have a ureR homolog, a regulatory gene that
is present in some bacteria with urea-inducible urease
[15]. Reverse transcriptase PCR demonstrated that the H.
influenzae urease gene cluster is transcribed as a single
transcript (Figure 7).
Urease activity in H. influenzae was dependent on
nitrogen (ammonium chloride) availability as activity
was maximal in the absence of added ammonium chlor-
ide and was markedly reduced as the concentration
increased (Figure 6). This down regulation of urease
expression by nitrogen sources is observed in other bac-
teria, including Brucella abortus and Klebsiella aerogenes
and suggests that urease functions in assimilation of
nitrogen from urea [23,25]. Because urea is translocated
onto epithelial surfaces by secretory systems and in tis-
sue exudates, urea is present in epithelial lining fluid of
the human respiratory tract in concentrations approxi-
mately equal to that in plasma [46]. Thus, we speculate
that the urease of H. influenzae facilitates nitrogen
assimilation in the nutritionally limited environment of
the human airways and the middle ear space.
Two indirect lines of evidence have suggested that H.
influenzae expresses urease during human infection.
Mason et al [14] showed that urease H is expressed dur-
ing infection of the middle ear in chinchillas and Qu et
al [13] showed that urease C was expressed in markedly
increased abundance during growth in pooled human
sputum. The present study advances those observations
by showing directly that H. influenzae expresses urease
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Figure 9 Human antibody response to urease. Results of ELISAs
measuring serum IgG to purified recombinant urease C in serum
samples from adults with COPD who experienced exacerbations
due to H. influenzae. Patient numbers (N = 18) are noted on the X-
axis. The per cent changes from pre exacerbation to post
exacerbation are shown on the Y-axis. The cutoff value (dotted line)
for a significant increase in antibody level was determined by
averaging the difference between 8 control pairs of sera from
patients who had negative sputum cultures and were clinically
stable (see text).
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exacerbations of COPD. Paired pre and post infection
serum samples were subjected to ELISA with purified
recombinant urease C to characterize the antibody
response to urease following infection. Because the pre
infection serum samples were collected one month prior
to acquisition of the infecting strain of H. influenzae,a n
increase in the level of antibody to urease indicates the
development of new antibodies following infection. All
serum samples had detectable levels of antibody to
urease and 7 of 18 patients developed significantly
increased levels following infection compared to their
own pre infection levels (Figure 9). This frequency of
antibody response following bacterial infection is typical
as heterogeneity in immune responses to bacterial anti-
gens among individuals is a hallmark of COPD [47,48].
Note also that recombinant purified urease C was used
in the ELISA and this protein is only one of 3 proteins
that comprise the urease complex; thus, a urease C-
based ELISA may underestimate the frequency of new
antibody responses to urease following infection. These
results indicate that H. influenzae expresses urease dur-
ing exacerbations of COPD and that urease is a target
of human antibody responses.
An important result from the present study is the
observation that urease functions to mediate survival of
H. influenzae in an acid environment. Urease mediates
survival in low pH as a virulence mechanism in other
bacteria, notably H. pylori which must survive in the
stomach. Other selected respiratory pathogens express
urease but the role of urease in pathogenesis of respira-
tory tract infection is unclear [49,50]. Microenviron-
ments in the human respiratory tract are likely low pH,
consistent with the speculation that the high level of
expression of urease in the respiratory tract mediates
survival in acid microenvironments. Furthermore, H.
influenzae is now known to invade and persist in
respiratory epithelial cells and macrophages, suggesting
that withstanding lower pH in intracellular compart-
ments may be a virulence mechanism [51-53].
Conclusions
The present study demonstrates that 1) The ureA-ureH
gene cluster of H. influenzae is exclusively responsible for
urease production because knock out mutants show no
urease activity. 2) Genes of the urease gene cluster are tran-
scribed as a single transcript. 3) Urease expression is regu-
lated in response to nitrogen availability. 4) The optimal
70
60
50
40
30
20
10
0
Wild type ureC mutant ure operon
mutant
complemented
ureC mutant
%
 
s
u
r
v
i
v
a
l
no urea
50 mM urea
100 mM urea
Figure 10 Urease mediates survival at acid pH. Survival of H. influenzae strain 11P6H and urease mutants at pH 4. Bacteria were suspended in
buffer at pH 4 and incubated for 30 minutes at 37°C. Urea concentrations are as follows: white bars: no urea; gray bars: 50 mM urea; black bars:
100 mM. Bars indicate %survival calculated from colony counts performed at time 0 and 30 minutes. Values represent the mean of 3
independent experiments and error bars indicate standard deviation.
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sent in all strains of H. influenzae tested including otitis
media and COPD isolates. 6) Transcription of the ure
operon is up regulated when H. influenzae grows in human
sputum, consistent with the earlier observation established
by proteomics analysis [13]. 7) Urease is expressed in the
human airways during infection in adults with COPD and
is the target of human antibody responses. And 8) Urease
mediates survival of H. influenzae in an acid environment.
In view of the high level of expression of urease in the
respiratory tract, future work will focus on elucidating the
role of urease as a virulence factor for H. influenzae infec-
tion of the human respiratory tract.
Methods
Bacterial strains and growth conditions
H. influenzae 11P6H was isolated from the sputum of an
adult with COPD who was experiencing an exacerbation
as part of a prospective study at the Buffalo VA Medical
Center [54]. The following strains were also isolated
from the sputum of adults with COPD as part of the
same study: 14P14H1, 24P17H1, 27P5H1, 33P18H1,
43P2H1, 55P3H1, 66P33H1, 74P16H1, 91P18H1. Each
strain was isolated from a different subject.
H. influenzae strains 1749, 1826, 6699, 6700, 4R, 17R,
26R, 47R, P86 and P113 were isolated from middle ear
fluid obtained by tympanocentesis from children with
otitis media in either Buffalo NY or Rochester NY. All
strains were identified as H. influenzae by growth
requirement for hemin and nicotinamide adenine dinu-
cleotide (NAD), absence of porphyrin production and
absence of hemolysis. Each isolate was also subjected to
immunoblot assay with monoclonal antibody 7F3 that
recognizes outer membrane P6 to exclude the possibility
of non hemolytic H. haemolyticus [55].
H. influenzae was grown on chocolate agar at 37°C in
5% CO2 or in brain heart infusion broth supplemented
with hemin and NAD each at 10 μg/ml with shaking at
37°C. In selected experiments, H. influenzae was grown
in chemically defined media (Table 1).
Chemically competent E. coli strains Top10 and BL21
(DE3) were obtained from Invitrogen (Carlsbad, CA)
and were grown at 37°C on Luria-Bertani (LB) plates or
in LB broth supplemented with antibiotics as noted in
individual experiments. Plasmid pSPEC1 was kindly pro-
vided by Lauren Bakaletz and Robert Munson [39].
Construction of mutants
A mutant lacking ureC, the gene that encodes the alpha
subunit of urease, was constructed using overlap
Table 1 Composition of chemically defined media (CDM)
Reagent Concentration
NaCl 0.1 M
K2SO4 5.75 mM
Na2EDTA 4 mM
NH4Cl 4 mM
K2HPO4 2m M
KH2PO4 2m M
Thiamine HCl 6 μM
Thiamine pyrophosphate 1 μM
Pantothenic acid 8 μM
d-Biotin 12 μM
Glucose 0.5%
Hypoxanthine 0.375 mM
Uracil 0 .45 mM
L-aspartic acid 3.75 mM
L-glutamic acid HCl 7.5 mM
L-arginine 0.875 mM
Glycine HCl 0.225 mM
L-serine 0.475 mM
L-leucine 0.7 mM
L-isoleucine 0.225 mM
L-valine 0.525 mM
L-tyrosine 0.4 mM
L-cysteine HCl 0.35 mM
L-cystine 0.15 mM
L-proline 0.45 mM
L-tryptophan 0.4 mM
L-threonine 0.425 mM
L-phenylalanine 0.15 mM
L-asparagine 0.2 mM
L-glutamine 0.35 mM
L-histidine HCl 0.125 mM
L-methionine 0.1 mM
L-alanine 1.125 mM
L-lysine 0.35 mM
Glutathione reduced 0.15 mM
HEPES 42 mM
NaHCO3 0.125 mM
Na acetate trihydrate 6.25 mM
Choline chloride salt 0.05 mM
Myo-inositol 1 μM
MgCl2 2.5 mM
CaCl2 0.6 mM
Fe(NO3)3 0.1 mM
Nicotinamide adenine dinucleotide 0.02 mM
Protoporphyrin IX 0.02 mM
Histidine 6 μM
Triethanolamine 0 .01%
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Page 8 of 14extension PCR. The transforming DNA to accomplish
this was composed of 3 fragments: 1) a ~1 kb fragment
of DNA corresponding to sequence upstream of ureC,
2) the nonpolar kanamycin resistance cassette AphA-3
[56], 3) a ~1 kb fragment of DNA corresponding to
sequence downstream of ureC. Primers for each of the
fragments were designed with 10 bp overlaps with com-
plementary overlapping regions with the adjacent frag-
ment (Table 2). The 3 fragments were amplified using
the high fidelity DNA polymerase Pfu (Stratagene, Cedar
Creek, TX) and were purified using the Qiaquick PCR
purification kit (Qiagen, Valencia, CA). Amplicons were
mixed in the absence of additional primers in a PCR
with Pfu and were subjected to a PCR program consist-
ing of 10 cycles with a denaturing step at 94°C for 30
sec, an annealing step at 50°C for 1 min and an elonga-
tion step at 72°C for 5 min. The fusion product was
subsequently amplified by Pfu with primers 539frag1 5’
and 539frag3 3’ (Table 2). This amplicon consisted of
1020 bp sequence upstream of ureC and 1029 bp
sequence downstream of ureC flanking the kanamycin
cassette.
The fragment was transformed into H. influenzae
strain 11P6H which was made competent by the method
of Herriott et al [57] using the transformation protocol
of Poje and Redfield [58] as previously described [59].
Transformants were selected on chocolate agar contain-
ing 15 μg/ml of robostimycin. A mutant was obtained
(11P6HureC
-) and allelic exchange was verified by PCR
analysis and sequencing as detailed in Results.
A mutant in which the entire urease gene cluster was
knocked out and replaced with a kanamycin cassette
was constructed (11P6Hure
-) with the same strategy
using the primers noted in Table 2. The mutant was
verified by PCR analysis, Southern blot assay and
sequencing.
Complementation of ureC mutant
Complementation was accomplished by using the plas-
mid pSPEC1 [39]. A fragment containing the ureC gene
and 740 bp upstream to include the promoter of the
urease operon and 300 bp downstream was amplified
from genomic DNA of strain 11P6H and ligated into
pSPEC1 at BamHI and EcoRI restriction sites (Table 2).
After confirming the insert sequence of the resulting
plasmid (p UreCspec), H. influenzae 11P6H was electro-
porated with p UreCspec that had been methylated with
CpG methylase (New England Biolabs) in a 0.1-cm cuv-
ette (200 Ω, 2.5 kV, 25 μF). Cells were plated on choco-
late agar containing 200 μg/ml of spectinomycin,
incubated overnight and the complemented mutant
11P6H ureC
-(p UreCspec) was obtained. This comple-
mented mutant was grown in the presence of spectino-
mycin for all experiments.
Southern blot assay
Southern blot assays were performed with genomic
DNA restricted with EcoRI with the Hoefer TransVac
vacuum blotting unit following the manufacturer’s
instructions (Hoefer, SanFrancisco, CA). Probes were
biotinylated with the NEBlot Phototope kit (New Eng-
land BioLabs) and blots were developed with the Photo-
tope-Star Detection Kit (New England BioLabs) using
the manufacturer’s instructions.
Measurement of urease activity
Urease activity was determined by measuring the
amount of ammonia released from urea [25,60]. To pre-
pare whole bacterial cell extracts, overnight cultures (5
ml) were centrifuged at 2500 × g for 10 min at 4°C and
the pellet was suspended in 5 ml of phosphate buffered
saline (PBS) pH 7.5. Cells were disrupted by sonication
with three 10 second bursts (Branson Sonifier 450, out-
put control 5). One ml of the resulting suspension was
centrifuged at 16,000 × g for 2 min to remove unbroken
cells and 10 μl of the sonic extract were added to 200 μl
of PBS containing 50 mM urea and incubated at 37°C
for 30 min. To perform the urease assay, 125 μl of sonic
extract were mixed with 250 μl alkaline hypochlorite,
250 μl phenol nitroprusside and 1 ml of water and the
assay was incubated for 30 min at 37°C. A volume of
200 μl was removed and placed into wells of a 96 well
plate and the OD595 w a sm e a s u r e di na nE L I S Ap l a t e
reader. Urease activity was determined by the use of a
standard curve using NH4Cl (0.156 mM to 2.5 mM)
performed simultaneously with each assay. Urease activ-
ity was expressed in μmoles of urea hydrolyzed per
minute.
Expression and purification of recombinant protein
encoded by ureC
The ureC gene was amplified by PCR from genomic
DNA of H. influenzae strain 11P6H using oligonucleo-
tide primers noted in Table 2 and cloned into pET101
D-TOPO (Invitrogen, Carlsbad, CA), which places a 6
histidine tag on the carboxy terminus of the recombi-
nant protein, using manufacturer’s instructions. Chemi-
cally competent E. coli TOP10 cells were transformed
with the recombinant plasmid and transformants were
selected by plating on LB plates containing 50 μg/ml of
carbenicillin. The plasmid (p539) from a transformant
was confirmed to have the ureC gene by PCR and by
sequence determination. Plasmid p539 was purified
using the Qiagen plasmid mini purification system and
transformed into chemically competent E. coli BL21
(DE3) for expression. To express recombinant protein,
2.5 ml of overnight culture was used to inoculate 50 ml
of LB broth containing 300 μg/ml of carbenicillin.
When the culture reached an OD600 of ~0.6, expression
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Page 9 of 14Table 2 Oligonucleotide primer sequences
Primer Gene Direction Sequence
1
Construction of ureC mutant
539 frag1 5’ ureC upstream Forward 5’-GACCTTTACCCACAGCTAAT-3’
539 frag1 3’ ureC upstream Reverse 5’-TAGTTAGTCACTTGAAATTGTTA
ATGCCAT-3’
539 frag2 5’ Kanamycin cassette Forward 5’-CAATTTCAAGTGACTAACTAGGA
GGAATAA-3’
539frag2 3’ Kanamycin cassette Reverse 5’-TGACCCAATGCATTATTCCCTCC
AGGTACT-3’
539 frag3 5’ ureC downstream Forward 5’-GGGAATAATGCATTGGGTCAGC
GATA-3’
539 frag3 3’ ureC downstream Reverse 5’-ATCGCACACCGAGTTTG-3’
Cloning of ureC into pSPEC1 to complement ureC mutation
539promoter
F1
ureA upstream Forward 5’-GAGAGGATCCGTAAAATTCGCTG
ACTTTCG-3’
539C R1 ureC downstream Reverse 5’-ATATGAATTCGCTACTTCACGCC
CCGTA-3’
Construction of urease operon mutant
539 Op frag1 F1 ureA upstream Forward 5’-TACACCTTCCTTGCCCAC-3’
539 Op frag1 R1 ureA upstream Reverse 5’-TAGTTAGTCAATTTTCATTCCTTAAT-3’
539 Op frag2 F1 Kanamycin cassette Forward 5’-GAATGAAAATTGACTAACTAG
GAGGAATAA-3’
539 Op frag2 R1 Kanamycin cassette Reverse 5’-ACCAATTTTCCATTATTCCCTCCA
GGTACT-3’
539Op frag3 F1 ureA downstream Forward 5’-GGGAATAATGGAAAATTGGTAG
GCTAT-3’
539Op frag3 R1 ureA downstream Reverse 5’-CAGATGTTGCTTCAATTAAG-3’
Subjecting multiple strains to PCR to assess presence of urease operon
UreaseA F1 ureA Forward 5’-ATGCACTTAACTTCCAGAG-3’
UreaseA R1 ureA Reverse 5’-TTATCTGATTGGATTATGC-3’
539 F1 ureC Forward 5’-CAACATGGCATTAACAATTTCAAG-3’
539 R1 ureC Reverse 5’-TTAGAATAGGAAATATCGCTG-3’
UreaseH F1 ureH Forward 5’-ATGAACAGTAAATTATCC-3’
UreaseHR1 ureH Reverse 5’-GAATTTGCTCTGCACGACA-3’
Cloning of ureC gene to express recombinant protein
539 F1 ureC Forward 5’-CAACATGGCATTAACAATTTCAAG-3’
539 R1 ureC Reverse 5’-TTAGAATAGGAAATATCGCTG-3’
Performing RT PCR
UreA-UreB F1 ureA, ureB Forward 5’-ATGAGTGTAGCGGAAGTG-3’
UreA-UreB R1 ureA, ureB Reverse 5’-ACGTTTAAACGCATTCCGC-3’
UreB-UreC F1 ureB, ureC Forward 5’-TGAAACCAATAATGCCCT-3’
UreB-UreC R1 ureB, ureC Reverse 5’-TTGCGTGCGTACCATCAGC-3’
UreC-UreE F1 ureC, ureE Forward 5’-GGTATTGCGGAGCATATTGG-3’
UreC-UreE R1 ureC, ureE Reverse 5’-GAATGACTGTGAGAATGCC-3’
UreE-UreF F1 ureE, ureF Forward 5’-GCTTGAAACACGATGATG-3’
UreE-UreF R1 ureE, ureF Reverse 5’-TGATTGCACCGACTGCTG-3’
UreF-UreG F1 ureF, ureG Forward 5’-TGCCTTCGATGCAATGAAC-3’
UreF-UreG R1 ureF, ureG Reverse 5’-AGCACCAACGAATGGAGC-3’
UreG-UreH F1 ureG, ureH Forward 5’-AGTTTGCTTCCACCAGAGC-3’
UreG-UreH R1 ureG, ureH Reverse 5’-GTTCGTCATTCAACACCC-3’
1underlined sequence denotes restriction enzyme site or cloning site
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Page 10 of 14was induced by the addition of IPTG to a concentration
of 4 mM. Cells were harvested by centrifugation after 4
hours and recombinant protein was purified with Talon
Metal Affinity resin (Clontech, Mountain View, CA)
using manufacturer’s instructions.
The purified recombinant protein was refolded by dia-
lysis in buffer with sequentially decreasing concentra-
tions of L-arginine. The buffer contained 0.15 M NaCl,
20 mM tris pH 9, with decreasing concentrations (1 M,
0.5 M, 5 mM) of L-arginine. Protease Arrest™ (EMD
Chemicals, Gibbstown NJ) was added to purified
protein.
Development of antiserum to urease C
Purified recombinant urease C was sent to Covance
(Denver, PA) for antibody production in New Zealand
white rabbits using a 59 day protocol. All applicable reg-
ulations for animal treatment were followed in accor-
dance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National
Institutes of Health (http://oacu.od.nih.gov/regs/guide/
guide.pdf). Specific pathogen free rabbits received 250
μg of purified protein with complete Freund’sa d j u v a n t
subcutaneously on day 0, followed by 125 μgo fp r o t e i n
with incomplete Freund’s adjuvant subcutaneously on
days 21 and 49. Blood was obtained on day 59.
The rabbit antiserum was adsorbed with 11P6H ureC
-
(urease C mutant) to remove background rabbit antibo-
dies to H. influenzae. To accomplish this, bacteria were
grown to log phase in broth, centrifuged to pellet bac-
teria, washed in PBS and suspended in 1 ml of a 1:1000
dilution of rabbit antiserum. After incubation for 30
min at 4°C, bacteria were removed by centrifugation.
This process was repeated 3 more times. After the last
adsorption, the serum was filter sterilized.
Reverse transcriptase-PCR
Bacteria were grown in chemically defined media (Table
1) and RNA was isolated using a QIAGEN RNeasy kit
and a Qiashredder column (QIAGEN, Valencia, CA) fol-
lowing the manufacturer’s instructions, with an addi-
tional incubation with RNase-free DNaseI (Promega) for
30 min at 37°C. Reverse transcriptase PCR (RT-PCR)
was performed using a QIAGEN OneStep RT-PCR kit
and RNaseOut inhibitor (Invitrogen, Carlsbad, CA). Pri-
mers were designed to amplify fragments that would be
predicted to correspond to transcripts that span adjacent
genes in the urease gene cluster (Table 2). To exclude
the possibility of contaminating DNA, parallel reactions
with Taq DNA polymerase (HotMaster Mix; Eppendorf,
Hamburg, Germany) were performed. Following amplifi-
cation, samples were electrophoresed in 1% agarose gels
and stained with ethidium bromide.
COPD Study Clinic
The COPD study clinic at the Buffalo Veterans Affairs
Medical Center is an ongoing prospective study that
was started in 1994 [54]. The study was approved by
the Health Sciences Institutional Review Board of the
University at Buffalo and the Human Studies Subcom-
mittee of the Western New York Veterans Affairs
Healthcare System. All study participants provided
written informed consent. To be included in this
study, patients must have chronic bronchitis as defined
by the American Thoracic Society [61] and must be
willing to attend the study clinic monthly. Patients
with asthma, malignancies, or other immunocompro-
mising illnesses were excluded. Patients were seen
monthly and at times when an exacerbation was sus-
pected. At each visit clinical criteria were used to
determine whether patients were experiencing an
exacerbation or whether they were clinically stable as
previously described [54]. Additionally at each visit,
serum and expectorated sputum samples were col-
lected. Bacteria present in the sputum were identified
using standard techniques. Serum and bacteria
obtained from sputum cultures were stored at -80°C.
An exacerbation of COPD caused by H. influenzae
was defined by the onset of clinical symptoms of an
exacerbation simultaneous with the acquisition of a new
strain of H. influenzae that had not previously been iso-
l a t e df r o mt h a tp a t i e n tb a s e do nm o l e c u l a rt y p i n g[ 5 4 ] .
Serum samples collected one month prior to acquisition
of the strain and one month following the exacerbation
were used to analyze human serum antibody responses
to the purified recombinant urease C.
Pooled human sputum
Expectorated sputum samples were collected from sub-
jects in the COPD Study Clinic and were processed for
culture as previously described [54,62]. Briefly, sputum
samples were homogenized by incubation at 37°C for 15
minutes with an equal volume of 0.1% dithiothreitol.
After an aliquot was removed for quantitative culture,
sputum samples were centrifuged at 27,000 × g for 30
minutes at 4°C and supernatants were stored at -80°C
until used. Samples from patients who were receiving
antibiotics and samples that grew potential pulmonary
bacterial pathogens in culture were excluded. Superna-
tants from approximately 100 sputum samples from 30
individuals were pooled for the purpose of growing bac-
teria in pooled sputum supernatants [13]. To render the
sputum supernatants sterile, the pooled samples were
placed in Petri dishes and exposed to UV light in a cell
culture hood for approximately 10 minutes. An aliquot
was plated on chocolate agar and no growth was
detected after overnight incubation.
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Page 11 of 14Quantitative real time PCR
H. influenzae was grown in the presence pooled human
sputum from adults with COPD to simulate conditions
in the human respiratory tract. To assess transcription
of ureC, strain 11P6H was grown overnight in chemi-
cally defined media (CDM) at 37°C with shaking to
which pooled human sputum supernatant of 20% of the
volume of the culture was added [13]. A second culture
was grown simultaneously in CDM to which PBS con-
taining 0.1% dithiothreitol was added to 20% of the total
volume as a control for the sputum supernatant. Cells
were harvested by centrifugation at 10,000 × g for 10
minutes at 4°C. Cells were washed by suspending in
cold PBS and centrifuging again using the same condi-
tions. Bacterial RNA was isolated as described above
(Reverse Transcriptase-PCR).
Quantitative real time PCR was performed using the
BioRad MyiQ Real-Time PCR Detection System. Oligo-
nucleotide primers pairs (Table 2) were designed with
Primer 3 software. Each reaction mixture contained 5
ng purified RNA, 100 nM of each primer, 12.5 μl2×
Sybr Green Supermix (BioRad), 0.125 μl reverse tran-
scriptase and 6.375 μl water. Controls lacking reverse
transcriptase or RNA template contained the appropri-
ate volume of water in place of enzyme or template.
Each purified RNA sample was tested for DNA con-
tamination prior to proceeding with the real time PCR
assay. Results with gyrA, a constitutively expressed
gene, were measured in both growth conditions and
used to normalize the results with ureC in the corre-
sponding growth condition. These normalized results
were used to calculate the fold change expression of
ureC during growth in CDM plus sputum compared to
CDM alone. BioRad iQ5 software was used to analyze
data.
Enzyme-linked immunosorbent assay (ELISA)
Eighteen pre and post exacerbation serum pairs from
adults with COPD followed in the COPD Study Clinic
were subjected to ELISA to detect the development of
new IgG antibodies in serum to urease C [48]. The
change in antibody level from pre-exacerbation to post-
exacerbation samples was calculated using the following
formula: % change = [( post OD - pre OD )/pre OD] ×
100. Paired pre-exacerbation and post-exacerbation sam-
ples were always tested in the same assay. The cutoff
value for a significant percentage change between pre-
exacerbation and post-exacerbation serum IgG levels
was determined by studying 8 control pairs of serum
samples obtained 2 months apart (the same time inter-
val for the experimental samples) from patients who
were clinically stable and who had negative sputum cul-
tures for H. influenzae as described previously
[42,43,48,63].
Susceptibility of H. influenzae to acid
H. influenzae wild type and mutant strains were grown
in broth to log phase, harvested by centrifugation and
suspended to a concentration of ~10
7 colony forming
units/ml in PBS adjusted to varying pH. Cells were incu-
bated in the presence or absence of urea (50 mM or 100
mM) and dilutions of bacteria were plated at time 0 and
at 30 min. Bacteria were counted after overnight incuba-
tion on chocolate agar.
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